StockMacro
Company, fund or insider

Help

Menu

Trevi Therapeutics

$13.35 -7.2% in 6 monthsMarket cap $1.9B

TRVI on XNAS, Health Care, Trevi Therapeutics, Inc., job postings

Measures activity, not value. Not investment advice.

Shares up 25% in 12 months but Trevi lost $60.8M and burned $61.7M of free cash.

  • BadShort interest 12% of shares, up 5.3% in two weeks

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.

Industry
Pharmaceutical preparations (Health Care)
Employees
34
Website
trevitherapeutics.com
Listed
Nasdaq, US
Last results
9 Nov 2026
Next results
expected around 16 Mar 2027 (an estimate: a year ago it reported on 17 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $21.5M.
Quarter to 31 Dec 2021: revenue –, net income -$8.5MQuarter to 31 Mar 2022: revenue –, net income -$7.3MQuarter to 30 Jun 2022: revenue –, net income -$8.1MQuarter to 30 Sep 2022: revenue –, net income -$8.3MQuarter to 31 Dec 2022: revenue –, net income -$5.5MQuarter to 31 Mar 2023: revenue –, net income -$6.4MQuarter to 30 Jun 2023: revenue –, net income -$7.1MQuarter to 30 Sep 2023: revenue –, net income -$7.7MQuarter to 31 Dec 2023: revenue –, net income -$7.8MQuarter to 31 Mar 2024: revenue –, net income -$10.9MQuarter to 30 Jun 2024: revenue –, net income -$12.4MQuarter to 30 Sep 2024: revenue –, net income -$13.2MQuarter to 31 Dec 2024: revenue –, net income -$11.4MQuarter to 31 Mar 2025: revenue –, net income -$10.3MQuarter to 30 Jun 2025: revenue –, net income -$12.3MQuarter to 30 Sep 2025: revenue –, net income -$11.8MQuarter to 31 Dec 2025: revenue –, net income -$8.3MQuarter to 31 Mar 2026: revenue –, net income -$13.2MQuarter to 30 Jun 2026: revenue –, net income -$17.8MQuarter to 30 Sep 2026: revenue –, net income -$21.5M
31 Dec 2021RevenueNet incomeNet losstallest bar $21.5M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$21.5M
30 Jun 2026–-$17.8M
31 Mar 2026–-$13.2M
31 Dec 2025–-$8.3M
30 Sep 2025–-$11.8M
30 Jun 2025–-$12.3M
31 Mar 2025–-$10.3M
31 Dec 2024–-$11.4M
30 Sep 2024–-$13.2M
30 Jun 2024–-$12.4M
31 Mar 2024–-$10.9M
31 Dec 2023–-$7.8M
30 Sep 2023–-$7.7M
30 Jun 2023–-$7.1M
31 Mar 2023–-$6.4M
31 Dec 2022–-$5.5M
30 Sep 2022–-$8.3M
30 Jun 2022–-$8.1M
31 Mar 2022–-$7.3M
31 Dec 2021–-$8.5M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$60.8M -$45.9M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.39 -$0.37
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -24.7% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$61.7M –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $299.4M $194.9M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$299.4M (net cash) –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $2.12
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 6.3 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Trevi TherapeuticsTRVI (this company) $1.9Bloss–––
Harmony BiosciencesHRMY $1.9B10.71.9+20%18.1%
BiohavenBHVN $1.9Bloss–––
ImmunomeIMNM $1.9Bloss–––
Vera TherapeuticsVERA $1.8Bloss–––
Aurinia PharmaceuticalsAUPH $2.0B6.36.1+21%97.7%

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$596K

bought $0, sold $596K

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+3.3%

222 13F filers vs 215

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

151.2M shares held by 13F filers (30 Sep 2026) of 142.6M outstanding (31 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

12%

16.9M shares sold short (30 Oct 2026) of 142.6M outstanding (31 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

10.1

16.9M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+5.3%

16.0M shares sold short in the report before, 16.9M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

28%

28% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 57%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

6

6 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

6.0×

6 articles in the last 7 days; its usual week has 1.

Price $13.35 on 20 Nov 2026, +25% over 12 months (12-month range $9.99 to $19.50)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $596K in the last 12 months (the 12 months before: -$601K).
Capital spending per quarter. Capital spending $25K in the latest quarter, +108% on a year earlier.
Institutional holders (13F filers). 222 13F filers reported holding it in the latest 13F quarter, +39% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
5 Dec 20258-K and other filingsDirector or officer change
5 Dec 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Aug 20258-K and other filingsDirector or officer change
17 Jun 2025Sharp changeShort interest spike: short interest spike, 7.0M vs usual 1.7M (2025-05-30); 8.3x the same period a year earlier
17 Jun 20258-K and other filingsDirector or officer change
17 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
3 Jun 2025Sharp changeShort interest spike: short interest spike, 6.9M vs usual 1.6M (2025-05-15); 7.0x the same period a year earlier
13 May 2025Sharp changeShort interest spike: short interest spike, 7.0M vs usual 1.5M (2025-04-30); 6.6x the same period a year earlier
29 Apr 2025Sharp changeShort interest spike: short interest spike, 5.9M vs usual 1.5M (2025-04-15); 6.6x the same period a year earlier
15 Apr 2025Sharp changeShort interest spike: short interest spike, 5.5M vs usual 1.5M (2025-03-31); 5.3x the same period a year earlier
1 Apr 2025Sharp changeShort interest spike: short interest spike, 4.7M vs usual 1.5M (2025-03-14); 4.4x the same period a year earlier
18 Mar 2025Sharp changeShort interest spike: short interest spike, 3.8M vs usual 1.4M (2025-02-28); 3.1x the same period a year earlier
4 Mar 2025Sharp changeShort interest spike: short interest spike, 4.3M vs usual 1.3M (2025-02-14); 3.6x the same period a year earlier
18 Feb 2025Sharp changeShort interest spike: short interest spike, 4.6M vs usual 1.3M (2025-01-31); 3.3x the same period a year earlier
28 Jan 2025Sharp changeShort interest spike: short interest spike, 4.1M vs usual 1.3M (2025-01-15); 3.3x the same period a year earlier
14 Jan 2025Sharp changeShort interest spike: short interest spike, 3.9M vs usual 1.3M (2024-12-31); 3.3x the same period a year earlier
31 Dec 2024Sharp changeShort interest spike: short interest spike, 4.7M vs usual 1.2M (2024-12-13); 4.6x the same period a year earlier
30 Sep 20248-K and other filingsDirector or officer change
30 Sep 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Dec 2023Sharp changeShort interest spike: short interest spike, 1.1M vs usual 245K (2023-11-30); 4.5x the same period a year earlier
28 Nov 2023Sharp changeShort interest spike: short interest spike, 1.1M vs usual 245K (2023-11-15); 3.9x the same period a year earlier
14 Nov 2023Sharp changeShort interest spike: short interest spike, 1.2M vs usual 245K (2023-10-31); 3.9x the same period a year earlier
31 Oct 2023Sharp changeShort interest spike: short interest spike, 1.2M vs usual 245K (2023-10-13); 3.0x the same period a year earlier
17 Oct 2023Sharp changeShort interest spike: short interest spike, 1.3M vs usual 243K (2023-09-29); 11.3x the same period a year earlier
3 Oct 2023Sharp changeShort interest spike: short interest spike, 1.3M vs usual 235K (2023-09-15); 13.4x the same period a year earlier
19 Sep 2023Sharp changeShort interest spike: short interest spike, 1.3M vs usual 215K (2023-08-31); 12.0x the same period a year earlier
29 Aug 2023Sharp changeShort interest spike: short interest spike, 1.4M vs usual 188K (2023-08-15); 12.1x the same period a year earlier
15 Aug 2023Sharp changeShort interest spike: short interest spike, 1.3M vs usual 167K (2023-07-31); 9.5x the same period a year earlier
1 Aug 2023Sharp changeShort interest spike: short interest spike, 1.3M vs usual 167K (2023-07-14); 6.6x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 1.3M vs usual 149K (2023-06-30); 13.4x the same period a year earlier
3 May 2022Sharp changeShort interest spike: short interest spike, 549K vs usual 88K (2022-04-14); 6.2x the same period a year earlier
18 Apr 20228-K and other filingsPrivate placement of securities (Form D)
14 Apr 2022Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 11.8M)
29 Mar 2022Sharp changeShort interest spike: short interest spike, 832K vs usual 88K (2022-03-15); 6.6x the same period a year earlier
15 Mar 2022Sharp changeShort interest spike: short interest spike, 591K vs usual 87K (2022-02-28); 10.9x the same period a year earlier
14 Jan 20228-K and other filingsDelisting notice or listing transfer
Insider net buying (open market)
Month from 1 Apr 2022: $11.8M published
Month from 1 May 2022: -$66K published
Month from 1 Jul 2022: -$2.8M published
Month from 1 Feb 2023: -$21K published
Month from 1 Mar 2023: -$2K published
Month from 1 Apr 2023: -$2K published
Month from 1 May 2023: -$2K published
Month from 1 Jun 2023: -$2K published
Month from 1 Jul 2023: -$2K published
Month from 1 Aug 2023: -$2K published
Month from 1 Sep 2023: -$2K published
Month from 1 Oct 2023: -$2K published
Month from 1 May 2024: -$96K published
Month from 1 Jun 2024: -$136K published
Month from 1 Aug 2024: -$150K published
Month from 1 Sep 2024: -$188K published
Month from 1 Mar 2025: -$601K published
Month from 1 Sep 2026: -$596K published
Capital spending per quarter
Quarter ended 31 Dec 2022: $116K; public on 17 Mar 2023
Quarter ended 31 Mar 2023: $57K; public on 12 May 2023
Quarter ended 30 Jun 2023: $40K; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $18K; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $22K, -81% on a year earlier; public on 21 Mar 2024
Quarter ended 30 Sep 2024: $0, -100% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $7K, -68% on a year earlier; public on 19 Mar 2025
Quarter ended 30 Sep 2025: $12K; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $0, -100% on a year earlier; public on 18 Mar 2026
Quarter ended 31 Mar 2026: $102K; public on 6 May 2026
Quarter ended 30 Jun 2026: $124K; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $25K, +108% on a year earlier; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 17; public on 14 Feb 2022
31 Mar 2022 report: 22; public on 16 May 2022
30 Jun 2022 report: 32; public on 15 Aug 2022
30 Sep 2022 report: 38; public on 14 Nov 2022
31 Dec 2022 report: 36; public on 14 Feb 2023
31 Mar 2023 report: 35; public on 15 May 2023
30 Jun 2023 report: 48; public on 14 Aug 2023
30 Sep 2023 report: 51; public on 14 Nov 2023
31 Dec 2023 report: 60; public on 14 Feb 2024
31 Mar 2024 report: 78; public on 15 May 2024
30 Jun 2024 report: 75; public on 14 Aug 2024
30 Sep 2024 report: 89; public on 14 Nov 2024
31 Dec 2024 report: 106; public on 14 Feb 2025
31 Mar 2025 report: 134; public on 15 May 2025
30 Jun 2025 report: 149; public on 14 Aug 2025
30 Sep 2025 report: 160; public on 14 Nov 2025
31 Dec 2025 report: 178; public on 17 Feb 2026
31 Mar 2026 report: 195; public on 15 May 2026
30 Jun 2026 report: 215; public on 14 Aug 2026
30 Sep 2026 report: 222; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $596K (17 Sep 2026), 14× its normal reading; higher than 93% of its own history.
  • Insider net buying (open market): Insiders sold a net $596K in the last 12 months (the 12 months before: -$601K).
  • Capital spending per quarter: Capital spending $25K in the latest quarter, +108% on a year earlier.
  • Institutional holders (13F filers): 222 13F filers reported holding it in the latest 13F quarter, +39% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 77 insider trades

Last 90 days: 1 sale, $596K; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
17 Sep 2026Michael Thomas HeffernanDirectorSellplanned in advance (10b5-1); after exercising options39,473$15.09$596KForm 4
26 Mar 2025Thomas SciasciaChief Scientific OfficerSellafter exercising options2,631$6.60$17KForm 4
25 Mar 2025Jennifer L GoodPresident & CEOSellafter exercising options5,263$6.58$35KForm 4
12 Mar 2025Farrell SimonChief Commercial OfficerSellplanned in advance (10b5-1); after exercising options81,313$6.75$549KForm 4
9 Sep 2024Jennifer L GoodPresident & CEOSellafter exercising options6,059$3.03$18KForm 4
5 Sep 2024Jennifer L GoodPresident & CEOSellafter exercising options55,121$3.09$170KForm 4
29 Aug 2024David P MeekerDirectorSellafter exercising options4,555$2.93$13KForm 4
21 Aug 2024Thomas SciasciaChief Scientific OfficerSellafter exercising options16,496$2.96$49KForm 4

222 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 34 opened a position, 28 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
FMR LLC (Fidelity)13.6M9.56%$195.2M+1.1M+8.5%
NEA Management Company, LLC13.2M9.27%$189.3MNo change
BlackRock, Inc.12.3M8.62%$176.0M+1.1M+10%
Frazier Life Sciences Management, L.P.9.5M6.69%$136.6M-400K-4.0%
Wellington Management Group LLP6.2M4.37%$89.3M+552K+9.7%
Vanguard Capital Management LLC6.1M4.29%$87.5M+582K+11%
Vivo Capital, LLC4.2M2.97%$60.6M-865K-17%
Assenagon Asset Management S.A.3.5M2.47%$50.5M+476K+16%
State Street Corp3.3M2.30%$46.9M+245K+8.1%
Marshall Wace, LLP3.2M2.21%$45.1M+477K+18%

Company events

All 34 company events

In 12 months: 1 director or officer change, 1 major agreement. Results releases and routine reports are left out.

FiledWhat happenedSource
17 Apr 2026Signed a major agreement8-K
5 Dec 2025Director or officer change8-K
20 Aug 2025Director or officer change8-K
17 Jun 2025Director or officer changeSame filing: shareholder vote results8-K
4 Jun 2025Signed a major agreement8-K
16 Dec 2024Signed a major agreement8-K
30 Sep 2024Director or officer change8-K
23 Sep 2022Signed a major agreement8-K

The 5 newest of 77 articles that name the company.

Timeline
Kind of data

Several things at once

Two or more unrelated kinds of records unusual within 30 days

14 Apr 2022confirmed

Confirmed across sources Insiders and Short interest and volume

Trevi Therapeutics (TRVI): had 3 insiders buy $11.8M of its shares on the open market within 30 days (3 filings), while it had 549K shares sold short in the 14 Apr 2022 report, 6.2× the same report last year. Two unrelated kinds of activity within 49 days.

  • Short interest and volume: Short interest spike, became public on 10 Mar 2022
  • Short interest and volume: Short interest spike, became public on 25 Mar 2022
  • Insiders: Clustered insider buying, became public on 14 Apr 2022
  • Short interest and volume: Short interest spike, became public on 27 Apr 2022
2021-03-31: 67K2021-04-15: 89K2021-04-30: 62K2021-05-14: 84K2021-05-28: 94K2021-06-15: 88K2021-06-30: 86K2021-07-15: 101K2021-07-30: 73K2021-08-13: 81K2021-08-31: 61K2021-09-15: 88K2021-09-30: 111K2021-10-15: 140K2021-10-29: 160K2021-11-15: 146K2021-11-30: 85K2021-12-15: 99K2022-01-14: 75K2022-01-31: 78K2022-02-15: 153K2022-02-28: 591K2022-03-15: 832K2022-03-31: 329K2022-04-14: 549K
The 14 Apr 2022 report against the 24 reports before it. this reportearliernormal: 88K
See the evidence (4 changes)

Short interest and volume: Short interest spike became public on 10 Mar 2022

Trevi Therapeutics had 591K shares sold short in the 28 Feb 2022 report, 11× the same report last year.

This period
591K (the 28 Feb 2022 report)
Normal report (median of 24 earlier)
87K
Typical spread (median absolute deviation)
14K
How far from its usual level
+10.1
Same report last year
54K
History used
1,020 days
2021-02-12: 65K2021-02-26: 54K2021-03-15: 126K2021-03-31: 67K2021-04-15: 89K2021-04-30: 62K2021-05-14: 84K2021-05-28: 94K2021-06-15: 88K2021-06-30: 86K2021-07-15: 101K2021-07-30: 73K2021-08-13: 81K2021-08-31: 61K2021-09-15: 88K2021-09-30: 111K2021-10-15: 140K2021-10-29: 160K2021-11-15: 146K2021-11-30: 85K2021-12-15: 99K2022-01-14: 75K2022-01-31: 78K2022-02-15: 153K2022-02-28: 591K
the 28 Feb 2022 report24 earlier reportsnormal: 87K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Mar 2022

Trevi Therapeutics had 832K shares sold short in the 15 Mar 2022 report, 6.6× the same report last year.

This period
832K (the 15 Mar 2022 report)
Normal report (median of 24 earlier)
88K
Typical spread (median absolute deviation)
14K
How far from its usual level
+14.9
Same report last year
126K
History used
1,035 days
2021-02-26: 54K2021-03-15: 126K2021-03-31: 67K2021-04-15: 89K2021-04-30: 62K2021-05-14: 84K2021-05-28: 94K2021-06-15: 88K2021-06-30: 86K2021-07-15: 101K2021-07-30: 73K2021-08-13: 81K2021-08-31: 61K2021-09-15: 88K2021-09-30: 111K2021-10-15: 140K2021-10-29: 160K2021-11-15: 146K2021-11-30: 85K2021-12-15: 99K2022-01-14: 75K2022-01-31: 78K2022-02-15: 153K2022-02-28: 591K2022-03-15: 832K
the 15 Mar 2022 report24 earlier reportsnormal: 88K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Insiders: Clustered insider buying became public on 14 Apr 2022

Trevi Therapeutics had 3 insiders buy $11.8M of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$11.8M
Window
15 Mar 2022 to 14 Apr 2022
  • BASKETT FOREST (ten percent owner) bought 2,631,578 shares of TRVI ($5.0M)dated 13 Apr 2022, public 14 Apr 2022
  • Behbahani Ali (ten percent owner) bought 3,580,526 shares of TRVI ($1.8M)dated 13 Apr 2022, public 14 Apr 2022
  • NEA 16 GP, LLC (ten percent owner) and 2 other(s) bought 2,631,578 shares of TRVI ($5.0M)dated 13 Apr 2022, public 14 Apr 2022

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Short interest and volume: Short interest spike became public on 27 Apr 2022

Trevi Therapeutics had 549K shares sold short in the 14 Apr 2022 report, 6.2× the same report last year.

This period
549K (the 14 Apr 2022 report)
Normal report (median of 24 earlier)
88K
Typical spread (median absolute deviation)
15K
How far from its usual level
+9.2
Same report last year
89K
History used
1,065 days
2021-03-31: 67K2021-04-15: 89K2021-04-30: 62K2021-05-14: 84K2021-05-28: 94K2021-06-15: 88K2021-06-30: 86K2021-07-15: 101K2021-07-30: 73K2021-08-13: 81K2021-08-31: 61K2021-09-15: 88K2021-09-30: 111K2021-10-15: 140K2021-10-29: 160K2021-11-15: 146K2021-11-30: 85K2021-12-15: 99K2022-01-14: 75K2022-01-31: 78K2022-02-15: 153K2022-02-28: 591K2022-03-15: 832K2022-03-31: 329K2022-04-14: 549K
the 14 Apr 2022 report24 earlier reportsnormal: 88K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 5 Dec 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 5 Dec 2025Filings record

    Director or officer change

  3. 20 Aug 2025Filings record

    Director or officer change

  4. 17 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  5. 17 Jun 2025Filings record

    Director or officer change

  6. 11 Jun 2025Short interest and volume change

    had 7.0M shares sold short in the 30 May 2025 report, 8.3× the same report last year.

    Same report last year: 850K; its normal report is 1.7M.

    See the evidence
    This period
    7.0M (the 30 May 2025 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    831K
    How far from its usual level
    +4.3
    Same report last year
    850K
    History used
    2,207 days
    2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M2025-01-31: 4.6M2025-02-14: 4.3M2025-02-28: 3.8M2025-03-14: 4.7M2025-03-31: 5.5M2025-04-15: 5.9M2025-04-30: 7.0M2025-05-15: 6.9M2025-05-30: 7.0M
    the 30 May 2025 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 28 May 2025Short interest and volume change

    had 6.9M shares sold short in the 15 May 2025 report, 7.0× the same report last year.

    Same report last year: 986K; its normal report is 1.6M.

    See the evidence
    This period
    6.9M (the 15 May 2025 report)
    Normal report (median of 24 earlier)
    1.6M
    Typical spread (median absolute deviation)
    676K
    How far from its usual level
    +5.2
    Same report last year
    986K
    History used
    2,192 days
    2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M2025-01-31: 4.6M2025-02-14: 4.3M2025-02-28: 3.8M2025-03-14: 4.7M2025-03-31: 5.5M2025-04-15: 5.9M2025-04-30: 7.0M2025-05-15: 6.9M
    the 15 May 2025 report24 earlier reportsnormal: 1.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  8. 10 May 2025Short interest and volume change

    had 7.0M shares sold short in the 30 Apr 2025 report, 6.6× the same report last year.

    Same report last year: 1.1M; its normal report is 1.5M.

    See the evidence
    This period
    7.0M (the 30 Apr 2025 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    565K
    How far from its usual level
    +6.5
    Same report last year
    1.1M
    History used
    2,177 days
    2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M2025-01-31: 4.6M2025-02-14: 4.3M2025-02-28: 3.8M2025-03-14: 4.7M2025-03-31: 5.5M2025-04-15: 5.9M2025-04-30: 7.0M
    the 30 Apr 2025 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 26 Apr 2025Short interest and volume change

    had 5.9M shares sold short in the 15 Apr 2025 report, 6.6× the same report last year.

    Same report last year: 898K; its normal report is 1.5M.

    See the evidence
    This period
    5.9M (the 15 Apr 2025 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    542K
    How far from its usual level
    +5.5
    Same report last year
    898K
    History used
    2,162 days
    2024-04-15: 898K2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M2025-01-31: 4.6M2025-02-14: 4.3M2025-02-28: 3.8M2025-03-14: 4.7M2025-03-31: 5.5M2025-04-15: 5.9M
    the 15 Apr 2025 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 10 Apr 2025Short interest and volume change

    had 5.5M shares sold short in the 31 Mar 2025 report, 5.3× the same report last year.

    Same report last year: 1.0M; its normal report is 1.5M.

    See the evidence
    This period
    5.5M (the 31 Mar 2025 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    487K
    How far from its usual level
    +5.5
    Same report last year
    1.0M
    History used
    2,147 days
    2024-03-28: 1.0M2024-04-15: 898K2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M2025-01-31: 4.6M2025-02-14: 4.3M2025-02-28: 3.8M2025-03-14: 4.7M2025-03-31: 5.5M
    the 31 Mar 2025 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 26 Mar 2025Short interest and volume change

    had 4.7M shares sold short in the 14 Mar 2025 report, 4.4× the same report last year.

    Same report last year: 1.1M; its normal report is 1.5M.

    See the evidence
    This period
    4.7M (the 14 Mar 2025 report)
    Normal report (median of 24 earlier)
    1.5M
    Typical spread (median absolute deviation)
    405K
    How far from its usual level
    +5.4
    Same report last year
    1.1M
    History used
    2,130 days
    2024-03-15: 1.1M2024-03-28: 1.0M2024-04-15: 898K2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M2025-01-31: 4.6M2025-02-14: 4.3M2025-02-28: 3.8M2025-03-14: 4.7M
    the 14 Mar 2025 report24 earlier reportsnormal: 1.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 12 Mar 2025Short interest and volume change

    had 3.8M shares sold short in the 28 Feb 2025 report, 3.1× the same report last year.

    Same report last year: 1.2M; its normal report is 1.4M.

    See the evidence
    This period
    3.8M (the 28 Feb 2025 report)
    Normal report (median of 24 earlier)
    1.4M
    Typical spread (median absolute deviation)
    349K
    How far from its usual level
    +4.6
    Same report last year
    1.2M
    History used
    2,116 days
    2024-02-29: 1.2M2024-03-15: 1.1M2024-03-28: 1.0M2024-04-15: 898K2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M2025-01-31: 4.6M2025-02-14: 4.3M2025-02-28: 3.8M
    the 28 Feb 2025 report24 earlier reportsnormal: 1.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 27 Feb 2025Short interest and volume change

    had 4.3M shares sold short in the 14 Feb 2025 report, 3.6× the same report last year.

    Same report last year: 1.2M; its normal report is 1.3M.

    See the evidence
    This period
    4.3M (the 14 Feb 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    294K
    How far from its usual level
    +6.9
    Same report last year
    1.2M
    History used
    2,102 days
    2024-02-15: 1.2M2024-02-29: 1.2M2024-03-15: 1.1M2024-03-28: 1.0M2024-04-15: 898K2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M2025-01-31: 4.6M2025-02-14: 4.3M
    the 14 Feb 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 12 Feb 2025Short interest and volume change

    had 4.6M shares sold short in the 31 Jan 2025 report, 3.3× the same report last year.

    Same report last year: 1.4M; its normal report is 1.3M.

    See the evidence
    This period
    4.6M (the 31 Jan 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    273K
    How far from its usual level
    +8.0
    Same report last year
    1.4M
    History used
    2,088 days
    2024-01-31: 1.4M2024-02-15: 1.2M2024-02-29: 1.2M2024-03-15: 1.1M2024-03-28: 1.0M2024-04-15: 898K2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M2025-01-31: 4.6M
    the 31 Jan 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 28 Jan 2025Short interest and volume change

    had 4.1M shares sold short in the 15 Jan 2025 report, 3.3× the same report last year.

    Same report last year: 1.2M; its normal report is 1.3M.

    See the evidence
    This period
    4.1M (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    232K
    How far from its usual level
    +8.3
    Same report last year
    1.2M
    History used
    2,072 days
    2024-01-12: 1.2M2024-01-31: 1.4M2024-02-15: 1.2M2024-02-29: 1.2M2024-03-15: 1.1M2024-03-28: 1.0M2024-04-15: 898K2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M2025-01-15: 4.1M
    the 15 Jan 2025 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 14 Jan 2025Short interest and volume change

    had 3.9M shares sold short in the 31 Dec 2024 report, 3.3× the same report last year.

    Same report last year: 1.2M; its normal report is 1.3M.

    See the evidence
    This period
    3.9M (the 31 Dec 2024 report)
    Normal report (median of 24 earlier)
    1.3M
    Typical spread (median absolute deviation)
    226K
    How far from its usual level
    +7.8
    Same report last year
    1.2M
    History used
    2,057 days
    2023-12-29: 1.2M2024-01-12: 1.2M2024-01-31: 1.4M2024-02-15: 1.2M2024-02-29: 1.2M2024-03-15: 1.1M2024-03-28: 1.0M2024-04-15: 898K2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M2024-12-31: 3.9M
    the 31 Dec 2024 report24 earlier reportsnormal: 1.3M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 25 Dec 2024Short interest and volume change

    had 4.7M shares sold short in the 13 Dec 2024 report, 4.6× the same report last year.

    Same report last year: 1.0M; its normal report is 1.2M.

    See the evidence
    This period
    4.7M (the 13 Dec 2024 report)
    Normal report (median of 24 earlier)
    1.2M
    Typical spread (median absolute deviation)
    209K
    How far from its usual level
    +11.0
    Same report last year
    1.0M
    History used
    2,039 days
    2023-12-15: 1.0M2023-12-29: 1.2M2024-01-12: 1.2M2024-01-31: 1.4M2024-02-15: 1.2M2024-02-29: 1.2M2024-03-15: 1.1M2024-03-28: 1.0M2024-04-15: 898K2024-04-30: 1.1M2024-05-15: 986K2024-05-31: 850K2024-06-14: 961K2024-06-28: 958K2024-07-15: 1.3M2024-07-31: 1.3M2024-08-15: 1.5M2024-08-30: 1.6M2024-09-13: 1.4M2024-09-30: 1.5M2024-10-15: 1.5M2024-10-31: 1.7M2024-11-15: 1.8M2024-11-29: 1.4M2024-12-13: 4.7M
    the 13 Dec 2024 report24 earlier reportsnormal: 1.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 30 Sep 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  19. 30 Sep 2024Filings record

    Director or officer change

  20. 12 Dec 2023Short interest and volume change

    had 1.1M shares sold short in the 30 Nov 2023 report, 4.5× the same report last year.

    Same report last year: 243K; its normal report is 245K.

    See the evidence
    This period
    1.1M (the 30 Nov 2023 report)
    Normal report (median of 24 earlier)
    245K
    Typical spread (median absolute deviation)
    162K
    How far from its usual level
    +3.5
    Same report last year
    243K
    History used
    1,660 days
    2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M2023-07-31: 1.3M2023-08-15: 1.4M2023-08-31: 1.3M2023-09-15: 1.3M2023-09-29: 1.3M2023-10-13: 1.2M2023-10-31: 1.2M2023-11-15: 1.1M2023-11-30: 1.1M
    the 30 Nov 2023 report24 earlier reportsnormal: 245K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 28 Nov 2023Short interest and volume change

    had 1.1M shares sold short in the 15 Nov 2023 report, 3.9× the same report last year.

    Same report last year: 290K; its normal report is 245K.

    See the evidence
    This period
    1.1M (the 15 Nov 2023 report)
    Normal report (median of 24 earlier)
    245K
    Typical spread (median absolute deviation)
    153K
    How far from its usual level
    +3.9
    Same report last year
    290K
    History used
    1,645 days
    2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M2023-07-31: 1.3M2023-08-15: 1.4M2023-08-31: 1.3M2023-09-15: 1.3M2023-09-29: 1.3M2023-10-13: 1.2M2023-10-31: 1.2M2023-11-15: 1.1M
    the 15 Nov 2023 report24 earlier reportsnormal: 245K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 10 Nov 2023Short interest and volume change

    had 1.2M shares sold short in the 31 Oct 2023 report, 3.9× the same report last year.

    Same report last year: 296K; its normal report is 245K.

    See the evidence
    This period
    1.2M (the 31 Oct 2023 report)
    Normal report (median of 24 earlier)
    245K
    Typical spread (median absolute deviation)
    150K
    How far from its usual level
    +4.1
    Same report last year
    296K
    History used
    1,630 days
    2022-10-31: 296K2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M2023-07-31: 1.3M2023-08-15: 1.4M2023-08-31: 1.3M2023-09-15: 1.3M2023-09-29: 1.3M2023-10-13: 1.2M2023-10-31: 1.2M
    the 31 Oct 2023 report24 earlier reportsnormal: 245K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 25 Oct 2023Short interest and volume change

    had 1.2M shares sold short in the 13 Oct 2023 report, 3.0× the same report last year.

    Same report last year: 405K; its normal report is 245K.

    See the evidence
    This period
    1.2M (the 13 Oct 2023 report)
    Normal report (median of 24 earlier)
    245K
    Typical spread (median absolute deviation)
    150K
    How far from its usual level
    +4.4
    Same report last year
    405K
    History used
    1,612 days
    2022-10-14: 405K2022-10-31: 296K2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M2023-07-31: 1.3M2023-08-15: 1.4M2023-08-31: 1.3M2023-09-15: 1.3M2023-09-29: 1.3M2023-10-13: 1.2M
    the 13 Oct 2023 report24 earlier reportsnormal: 245K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 12 Oct 2023Short interest and volume change

    had 1.3M shares sold short in the 29 Sep 2023 report, 11× the same report last year.

    Same report last year: 111K; its normal report is 243K.

    See the evidence
    This period
    1.3M (the 29 Sep 2023 report)
    Normal report (median of 24 earlier)
    243K
    Typical spread (median absolute deviation)
    139K
    How far from its usual level
    +4.9
    Same report last year
    111K
    History used
    1,598 days
    2022-09-30: 111K2022-10-14: 405K2022-10-31: 296K2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M2023-07-31: 1.3M2023-08-15: 1.4M2023-08-31: 1.3M2023-09-15: 1.3M2023-09-29: 1.3M
    the 29 Sep 2023 report24 earlier reportsnormal: 243K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 27 Sep 2023Short interest and volume change

    had 1.3M shares sold short in the 15 Sep 2023 report, 13× the same report last year.

    Same report last year: 99K; its normal report is 235K.

    See the evidence
    This period
    1.3M (the 15 Sep 2023 report)
    Normal report (median of 24 earlier)
    235K
    Typical spread (median absolute deviation)
    130K
    How far from its usual level
    +5.6
    Same report last year
    99K
    History used
    1,584 days
    2022-09-15: 99K2022-09-30: 111K2022-10-14: 405K2022-10-31: 296K2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M2023-07-31: 1.3M2023-08-15: 1.4M2023-08-31: 1.3M2023-09-15: 1.3M
    the 15 Sep 2023 report24 earlier reportsnormal: 235K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 13 Sep 2023Short interest and volume change

    had 1.3M shares sold short in the 31 Aug 2023 report, 12× the same report last year.

    Same report last year: 110K; its normal report is 215K.

    See the evidence
    This period
    1.3M (the 31 Aug 2023 report)
    Normal report (median of 24 earlier)
    215K
    Typical spread (median absolute deviation)
    104K
    How far from its usual level
    +7.1
    Same report last year
    110K
    History used
    1,569 days
    2022-08-31: 110K2022-09-15: 99K2022-09-30: 111K2022-10-14: 405K2022-10-31: 296K2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M2023-07-31: 1.3M2023-08-15: 1.4M2023-08-31: 1.3M
    the 31 Aug 2023 report24 earlier reportsnormal: 215K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 25 Aug 2023Short interest and volume change

    had 1.4M shares sold short in the 15 Aug 2023 report, 12× the same report last year.

    Same report last year: 112K; its normal report is 188K.

    See the evidence
    This period
    1.4M (the 15 Aug 2023 report)
    Normal report (median of 24 earlier)
    188K
    Typical spread (median absolute deviation)
    91K
    How far from its usual level
    +8.8
    Same report last year
    112K
    History used
    1,553 days
    2022-08-15: 112K2022-08-31: 110K2022-09-15: 99K2022-09-30: 111K2022-10-14: 405K2022-10-31: 296K2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M2023-07-31: 1.3M2023-08-15: 1.4M
    the 15 Aug 2023 report24 earlier reportsnormal: 188K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 10 Aug 2023Short interest and volume change

    had 1.3M shares sold short in the 31 Jul 2023 report, 9.5× the same report last year.

    Same report last year: 139K; its normal report is 167K.

    See the evidence
    This period
    1.3M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    167K
    Typical spread (median absolute deviation)
    74K
    How far from its usual level
    +10.6
    Same report last year
    139K
    History used
    1,538 days
    2022-07-29: 139K2022-08-15: 112K2022-08-31: 110K2022-09-15: 99K2022-09-30: 111K2022-10-14: 405K2022-10-31: 296K2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M2023-07-31: 1.3M
    the 31 Jul 2023 report24 earlier reportsnormal: 167K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 26 Jul 2023Short interest and volume change

    had 1.3M shares sold short in the 14 Jul 2023 report, 6.6× the same report last year.

    Same report last year: 198K; its normal report is 167K.

    See the evidence
    This period
    1.3M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    167K
    Typical spread (median absolute deviation)
    72K
    How far from its usual level
    +10.7
    Same report last year
    198K
    History used
    1,521 days
    2022-07-15: 198K2022-07-29: 139K2022-08-15: 112K2022-08-31: 110K2022-09-15: 99K2022-09-30: 111K2022-10-14: 405K2022-10-31: 296K2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M2023-07-14: 1.3M
    the 14 Jul 2023 report24 earlier reportsnormal: 167K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 13 Jul 2023Short interest and volume change

    had 1.3M shares sold short in the 30 Jun 2023 report, 13× the same report last year.

    Same report last year: 99K; its normal report is 149K.

    See the evidence
    This period
    1.3M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    149K
    Typical spread (median absolute deviation)
    54K
    How far from its usual level
    +14.8
    Same report last year
    99K
    History used
    1,507 days
    2022-06-30: 99K2022-07-15: 198K2022-07-29: 139K2022-08-15: 112K2022-08-31: 110K2022-09-15: 99K2022-09-30: 111K2022-10-14: 405K2022-10-31: 296K2022-11-15: 290K2022-11-30: 243K2022-12-15: 160K2022-12-30: 95K2023-01-13: 96K2023-01-31: 89K2023-02-15: 79K2023-02-28: 66K2023-03-15: 115K2023-03-31: 174K2023-04-14: 201K2023-04-28: 280K2023-05-15: 248K2023-05-31: 243K2023-06-15: 228K2023-06-30: 1.3M
    the 30 Jun 2023 report24 earlier reportsnormal: 149K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 27 Apr 2022Short interest and volume change

    had 549K shares sold short in the 14 Apr 2022 report, 6.2× the same report last year.

    Same report last year: 89K; its normal report is 88K.

    See the evidence
    This period
    549K (the 14 Apr 2022 report)
    Normal report (median of 24 earlier)
    88K
    Typical spread (median absolute deviation)
    15K
    How far from its usual level
    +9.2
    Same report last year
    89K
    History used
    1,065 days
    2021-03-31: 67K2021-04-15: 89K2021-04-30: 62K2021-05-14: 84K2021-05-28: 94K2021-06-15: 88K2021-06-30: 86K2021-07-15: 101K2021-07-30: 73K2021-08-13: 81K2021-08-31: 61K2021-09-15: 88K2021-09-30: 111K2021-10-15: 140K2021-10-29: 160K2021-11-15: 146K2021-11-30: 85K2021-12-15: 99K2022-01-14: 75K2022-01-31: 78K2022-02-15: 153K2022-02-28: 591K2022-03-15: 832K2022-03-31: 329K2022-04-14: 549K
    the 14 Apr 2022 report24 earlier reportsnormal: 88K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 18 Apr 2022Filings record

    Private placement of securities (Form D)

  33. 14 Apr 2022several at once

    had 3 insiders buy $11.8M of its shares on the open market within 30 days (3 filings), while it had 549K shares sold short in the 14 Apr 2022 report, 6.2× the same report last year. Two unrelated kinds of activity within 49 days.

    See the evidence (4 changes)

    Short interest and volume: Short interest spike became public on 10 Mar 2022

    Trevi Therapeutics had 591K shares sold short in the 28 Feb 2022 report, 11× the same report last year.

    This period
    591K (the 28 Feb 2022 report)
    Normal report (median of 24 earlier)
    87K
    Typical spread (median absolute deviation)
    14K
    How far from its usual level
    +10.1
    Same report last year
    54K
    History used
    1,020 days
    2021-02-12: 65K2021-02-26: 54K2021-03-15: 126K2021-03-31: 67K2021-04-15: 89K2021-04-30: 62K2021-05-14: 84K2021-05-28: 94K2021-06-15: 88K2021-06-30: 86K2021-07-15: 101K2021-07-30: 73K2021-08-13: 81K2021-08-31: 61K2021-09-15: 88K2021-09-30: 111K2021-10-15: 140K2021-10-29: 160K2021-11-15: 146K2021-11-30: 85K2021-12-15: 99K2022-01-14: 75K2022-01-31: 78K2022-02-15: 153K2022-02-28: 591K
    the 28 Feb 2022 report24 earlier reportsnormal: 87K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Mar 2022

    Trevi Therapeutics had 832K shares sold short in the 15 Mar 2022 report, 6.6× the same report last year.

    This period
    832K (the 15 Mar 2022 report)
    Normal report (median of 24 earlier)
    88K
    Typical spread (median absolute deviation)
    14K
    How far from its usual level
    +14.9
    Same report last year
    126K
    History used
    1,035 days
    2021-02-26: 54K2021-03-15: 126K2021-03-31: 67K2021-04-15: 89K2021-04-30: 62K2021-05-14: 84K2021-05-28: 94K2021-06-15: 88K2021-06-30: 86K2021-07-15: 101K2021-07-30: 73K2021-08-13: 81K2021-08-31: 61K2021-09-15: 88K2021-09-30: 111K2021-10-15: 140K2021-10-29: 160K2021-11-15: 146K2021-11-30: 85K2021-12-15: 99K2022-01-14: 75K2022-01-31: 78K2022-02-15: 153K2022-02-28: 591K2022-03-15: 832K
    the 15 Mar 2022 report24 earlier reportsnormal: 88K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Insiders: Clustered insider buying became public on 14 Apr 2022

    Trevi Therapeutics had 3 insiders buy $11.8M of its shares on the open market within 30 days (3 filings).

    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $11.8M
    Window
    15 Mar 2022 to 14 Apr 2022
    • BASKETT FOREST (ten percent owner) bought 2,631,578 shares of TRVI ($5.0M)dated 13 Apr 2022, public 14 Apr 2022
    • Behbahani Ali (ten percent owner) bought 3,580,526 shares of TRVI ($1.8M)dated 13 Apr 2022, public 14 Apr 2022
    • NEA 16 GP, LLC (ten percent owner) and 2 other(s) bought 2,631,578 shares of TRVI ($5.0M)dated 13 Apr 2022, public 14 Apr 2022

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Short interest and volume: Short interest spike became public on 27 Apr 2022

    Trevi Therapeutics had 549K shares sold short in the 14 Apr 2022 report, 6.2× the same report last year.

    This period
    549K (the 14 Apr 2022 report)
    Normal report (median of 24 earlier)
    88K
    Typical spread (median absolute deviation)
    15K
    How far from its usual level
    +9.2
    Same report last year
    89K
    History used
    1,065 days
    2021-03-31: 67K2021-04-15: 89K2021-04-30: 62K2021-05-14: 84K2021-05-28: 94K2021-06-15: 88K2021-06-30: 86K2021-07-15: 101K2021-07-30: 73K2021-08-13: 81K2021-08-31: 61K2021-09-15: 88K2021-09-30: 111K2021-10-15: 140K2021-10-29: 160K2021-11-15: 146K2021-11-30: 85K2021-12-15: 99K2022-01-14: 75K2022-01-31: 78K2022-02-15: 153K2022-02-28: 591K2022-03-15: 832K2022-03-31: 329K2022-04-14: 549K
    the 14 Apr 2022 report24 earlier reportsnormal: 88K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  34. 14 Apr 2022Insiders change

    had 3 insiders buy $11.8M of its shares on the open market within 30 days (3 filings).

    Who bought: Baskett Forest, Behbahani Ali.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $11.8M
    Window
    15 Mar 2022 to 14 Apr 2022
    • BASKETT FOREST (ten percent owner) bought 2,631,578 shares of TRVI ($5.0M)dated 13 Apr 2022, public 14 Apr 2022
    • Behbahani Ali (ten percent owner) bought 3,580,526 shares of TRVI ($1.8M)dated 13 Apr 2022, public 14 Apr 2022
    • NEA 16 GP, LLC (ten percent owner) and 2 other(s) bought 2,631,578 shares of TRVI ($5.0M)dated 13 Apr 2022, public 14 Apr 2022

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  35. 14 Apr 2022Insiders record

    BASKETT FOREST (ten percent owner) bought 2,631,578 shares of TRVI ($5.0M) (dated 13 Apr 2022)

  36. 14 Apr 2022Insiders record

    Behbahani Ali (ten percent owner) bought 3,580,526 shares of TRVI ($1.8M) (dated 13 Apr 2022)

  37. 14 Apr 2022Insiders record

    Walker Paul Edward (ten percent owner) bought 3,580,526 shares of TRVI [same transaction as an earlier filing] (dated 13 Apr 2022)

  38. 14 Apr 2022Insiders record

    Florence Anthony A. Jr. (ten percent owner) bought 3,580,526 shares of TRVI [same transaction as an earlier filing] (dated 13 Apr 2022)

  39. 14 Apr 2022Insiders record

    Makhzoumi Mohamad (ten percent owner) bought 3,580,526 shares of TRVI [same transaction as an earlier filing] (dated 13 Apr 2022)

  40. 14 Apr 2022Insiders record

    Chang Carmen (ten percent owner) bought 3,580,526 shares of TRVI [same transaction as an earlier filing] (dated 13 Apr 2022)

Showing the newest 40 of 101 entries; narrow the window or the kind of data to see older ones.

Not listed: 135 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001563880
Ticker
TRVI
Domain
trevitherapeutics.com
Hq location
CT|NEW HAVEN|06510 (1 unverified)
Name
Trevi Therapeutics, Inc.
  • SEC Form 13F institutional holdings270 data points30 Jun 2019 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)123 records24 Jul 2017 to 9 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)436 data points31 Dec 2017 to 31 Oct 2026
  • SEC Form 4 insider transactions77 records, 120 data points13 May 2019 to 17 Sep 2026
  • FINRA short interest (twice monthly)536 data points15 May 2019 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3762 data points7 May 2019 to 20 Nov 2026